Skip to main content
Premium Trial:

Request an Annual Quote

Branscomb Brings Life to DOE

Premium

Elbert Branscomb, former director of the Joint Genome Institute, claims he’s out of work. It’s not really that dire — Branscomb, recently appointed leader of DOE’s Bringing the Genome to Life project, is simply awaiting a new title.

Branscomb’s new position involves working on a plan for the future of genomics. This initiative, originally called “Bringing the Genome to Life: Energy Related Biology in the New Genomic World,” is also (fortunately) awaiting a new title. Branscomb hopes for something like “Genomes to Life.”

The first proposal came out in June, and more details were added at a public meeting in Washington last month. Ari Patrinos, a director at DOE, calls this step “a roadmap for its implementation.”

“We are now in a position to go very much faster into the mysteries of how life works than we were before,” Branscomb says. But he adds, “To do that we need to focus our energies differently.”

He says gathering data on a large scale remains an essential part of the genomics field, and that DOE will continue to play an important role. “We are persuaded that the department can bring to bear resources that are not as generously available elsewhere,” Branscomb says.

Let’s hope those resources include stationery with plenty of room for the project’s name, whatever it turns out to be.

— Meredith Salisbury

 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.